Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04212910 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 86 participants (planned 101) · Primary completion date changed from estimate of Dec 31, 2025 to Feb 28, 2025 · Study completion date changed from estimate of Feb 28, 2027 to Dec 1, 2025 · 3 more Show 6 more changesShow less
    • Final enrollment: 86 participants (planned 101)
    • Primary completion date changed from estimate of Dec 31, 2025 to Feb 28, 2025
    • Study completion date changed from estimate of Feb 28, 2027 to Dec 1, 2025
    • Eligibility criteria expanded, about 10 words
    • Site details revised
    • Publications: details revised at 3 of 3 entries
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2025 Completion date: Sep 28, 2027 to Feb 28, 2027v4 Show 1 more changeShow less
    • Completion date: Sep 28, 2027 to Feb 28, 2027
  3. Primary completion date: Sep 23, 2021 to Dec 31, 2023 Primary endpoints revised (7) · Completion date: Jul 28, 2024 to Sep 28, 2027v3 Show 2 more changesShow less
    • Primary endpoints revised (7)
    • Completion date: Jul 28, 2024 to Sep 28, 2027

    See this version in full on ClinicalTrials.gov ↗

  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.
Trial Details
NCT Number NCT04212910
Lead Sponsor IRCCS San Raffaele
Conditions Endometrium Cancer
Enrollment 86 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov